Quantcast
Last updated on April 21, 2014 at 1:20 EDT

Latest Lou Gehrig's disease Stories

2014-03-10 08:31:05

ROCKVILLE, Md., March 10, 2014 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) today provided an update on its clinical trials program and reported its 2013 financial results for the year ended December 31, 2013. (Logo: http://photos.prnewswire.com/prnh/20061221/DCTH007LOGO) "2013 was an exciting year for advancement in our NSI-566 cell therapy clinical programs," said Karl Johe, PhD, Neuralstem's Chairman of the Board and Chief Scientific Officer. "Our Phase II ALS trial...

2014-01-02 12:22:31

WASHINGTON, Jan. 2, 2014 /PRNewswire-USNewswire/ -- Numotion, the complex wheelchair company committed to serving the lifelong needs of people through individualized health and mobility solutions, has partnered with The ALS Association to offer support and enhance the quality of life for individuals affected by amyotrophic lateral sclerosis (ALS). (Logo: http://photos.prnewswire.com/prnh/20131211/MM32178LOGO) ALS, commonly known as Lou Gehrig's Disease, is a progressive...

2013-12-09 08:28:41

- Findings Show Positive Trends in Slowing Advancement of Disease, as well as Enhanced Activity of NP001 in Patients with Increased Baseline Inflammation - PALO ALTO, Calif., Dec. 9, 2013 /PRNewswire/ -- Neuraltus Pharmaceuticals, Inc. announced today that promising efficacy results of the Company's Phase 2 clinical program of NP001 for the treatment of amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease) were highlighted in an oral presentation at the 24th International...

2013-10-15 08:33:25

WASHINGTON, Oct. 15, 2013 /PRNewswire-USNewswire/ -- If he were here today, baseball's Lou Gehrig would be proud of his brothers from the Phi Delta Theta Fraternity. The Fraternity, of which Gehrig was a member during his days at Columbia University in the early 1920s, will be working with The ALS Association for a Service Learning Trip in May 2014. For this trip, Phi Delta Theta members will interact with people living with amyotrophic lateral sclerosis (ALS) and others from the ALS...

2013-05-06 08:31:22

WASHINGTON, May 6, 2013 /PRNewswire-USNewswire/ -- BAYADA Home Health Care is now a national partner of The ALS Association and a Walk to Defeat ALS® Gold National Team. The suburban Philadelphia, Pa.- based company, which provides nursing, rehabilitative, therapeutic, hospice, and assistive care services to children, adults, and seniors in the comfort of their homes, has joined forces with the national non-profit to raise awareness of amyotrophic lateral sclerosis (ALS), otherwise known...

2013-04-02 16:25:24

Rockefeller Plaza Exhibit Highlights Hope for the Growing Health Concern NEW YORK, April 2, 2013 /PRNewswire/ -- As the leader for research in ALS, the devastating brain disorder also known as Lou Gehrig's disease, Project A.L.S. has been selected by EHE International to raise awareness about ALS and related brain diseases in a 103-square foot window display in Rockefeller Plaza. The interactive Project A.L.S. exhibit debuts today in the major international thoroughfare, and will be...

2013-02-04 12:26:03

DALLAS, Feb. 4, 2013 /PRNewswire-USNewswire/ -- On February 8, The ALS Association and its Texas Chapter will honor two Texans who are bravely battling amyotrophic lateral sclerosis (ALS), otherwise known as Lou Gehrig's Disease, during the 3(rd) Annual Luncheon for Heroes Living with ALS. ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. Eventually, people with ALS lose the ability to initiate and control muscle movement, which often...

2013-01-08 08:31:35

CNS-targeted Liposomal Drug Delivery System Enhances Institute's Formulation Abilities CAMBRIDGE, Mass. and LEIDEN, Netherlands, Jan. 8, 2013 /PRNewswire-USNewswire/ -- The ALS Therapy Development Institute (ALS TDI) announced today that it has entered into a new collaboration with to-BBB to investigate potential treatments for ALS (aka Motor Neuron or Lou Gehrig's disease). (Logo: http://photos.prnewswire.com/prnh/20110204/DC42625LOGO) "This partnership brings a new potential tool to...

2012-11-08 12:27:38

Military Veterans Twice as Likely to Die From ALS as General Public WASHINGTON, Nov. 8, 2012 /PRNewswire-USNewswire/ -- For unknown reasons, people who have served in the military are twice as likely to die from Lou Gehrig's Disease as those in the general population. This Veterans Day, The ALS Association is again honoring veterans with amyotrophic lateral sclerosis (ALS) on its Wall of Honor at www.alsa.org/WallofHonor, which features stories and photos of veterans who waged and are...

2012-05-08 02:29:40

ROCKVILLE, Md., May 8, 2012 /PRNewswire/ -- Neuralstem, Inc. (NYSE Amex: CUR) announced that the Federal Drug Administration (FDA) has approved the return of three patients from earlier cohorts in its ongoing Phase I safety trial to treat amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) with its spinal cord stem cells (HSSC's). These patients will be permitted to return to the trial for second treatments as the next cohort of patients, provided they meet inclusion requirements at...